Market Research Logo

Global Autoimmune Disease Diagnostics Market 2017-2021

Global Autoimmune Disease Diagnostics Market 2017-2021

About the Autoimmune Disease Diagnostics Market

Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.

Technavio’s analysts forecast the global autoimmune disease diagnostics market to grow at a CAGR of 6.39% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global autoimmune disease diagnostics market for 2017-2021. To calculate the market size, we use the revenue generated from the sales of various diagnostic tests for autoimmune diseases.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Autoimmune Disease Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Laboratories
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Inova Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
Other prominent vendors
  • AESKU Diagnostics
  • Alere
  • Autoimmune Technologies
  • Bio-Diagnostics
  • bioMérieux
  • Diarect
  • DiaSorin
  • Erba Diagnostics
  • Euro Diagnostica
  • EUROIMMUN
  • Exagen Diagnostics
  • Gold Standard Diagnostics
  • HUMAN Diagnostics
  • ImmunArray
  • KRONUS
  • Menarini
  • Myriad Genetics
  • Omega Diagnostics
  • ORGENTEC Diagnostika
  • Protagen
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics
  • Seramun Diagnostica
  • SQI Diagnostics
  • Tecan
Market driver
  • Discovery of novel biomarkers
  • For a full, detailed list, view our report
Market challenge
  • Lack of skilled laboratory technicians
  • For a full, detailed list, view our report
Market trend
  • Shift from monoplex to multiplex testing
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Autoimmune Disease Diagnostics Market 2017-2021



Technavio recognizes the following companies as the key players in the global autoimmune disease diagnostics market: Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Inova Diagnostics, Siemens Healthcare, and Thermo Fisher Scientific.



Other Prominent Vendors in the market are: AESKU Diagnostics, Alere, Autoimmune Technologies, Bio-Diagnostics, bioMérieux, Diarect, DiaSorin, Erba Diagnostics, Euro Diagnostica, EUROIMMUN, Exagen Diagnostics, Gold Standard Diagnostics, HUMAN Diagnostics, ImmunArray, KRONUS, Menarini, Myriad Genetics, Omega Diagnostics, ORGENTEC Diagnostika, Protagen, Qiagen, Quest Diagnostics, Roche Diagnostics, Seramun Diagnostica, SQI Diagnostics, and Tecan.



Commenting on the report, an analyst from Technavio’s team said: “A trend contributing to market growth is the shift from monoplex to multiplex testing. The focus on multiplex testing is increasing, particularly in the area of in vitro diagnostics. Singleplex systems can analyze a single analyte from test samples for disease diagnosis. On the other hand, multiplexed assays can analyze samples by detecting multiple analytes from a single or multiple samples, offering a high-throughput solution. These multiplexed systems are cost-effective, require limited labor, and have increased efficiency and turnaround time in the delivery of results.”



According to the report, a key growth driver is the discovery of novel biomarkers. Autoimmune diseases are of various types, with each individual exhibiting different symptoms if affected by at least two disease types. This makes it difficult for physicians to diagnose disease types. Biomarkers linked to autoimmune diseases are currently being discovered and studied, which has led to the development of biomarker-specific new diagnostic products. For instance, in 2013, researchers in the University of Cincinnati, US, identified various protein-based biomarkers associated with inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis.



Further, the report states that one challenge that could restrict market growth is the lack of skilled lab technicians. Autoimmune disease diagnostics involve analysis and presentation, increasing the need for a thorough understanding and knowledge of autoimmune diseases. They also increase the need for a thorough understanding about biomarker-specific assays and the working of automated tests. However, most hospitals and research centers do not have technicians who are thorough with these automated systems. This has increased the demand for technicians who can operate the equipment and immunodiagnostic tests. This has also led many medical facilities to avoid using automated systems due to the unavailability of skilled technicians.







Companies Mentioned

Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Inova Diagnostics, Siemens Healthcare, Thermo Fisher Scientific, AESKU Diagnostics, Alere, Autoimmune Technologies, Bio-Diagnostics, bioMérieux, Diarect, DiaSorin, Erba Diagnostics, Euro Diagnostica, EUROIMMUN, Exagen Diagnostics, Gold Standard Diagnostics, HUMAN Diagnostics, ImmunArray, KRONUS, Menarini, Myriad Genetics, Omega Diagnostics, ORGENTEC Diagnostika, Protagen, Qiagen, Quest Diagnostics, Roche Diagnostics, Seramun Diagnostica, SQI Diagnostics, Tecan.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
    • Autoimmune diseases
      • Table Etiology of autoimmune diseases
      • Table Signs and symptoms of autoimmune diseases
      • Table Average annual treatment cost of RA in US and Europe 2014 ($ billions)
      • Table Average annual treatment costs of multiple sclerosis across countries 2014 ($ billions)
      • Table Snapshot of global autoimmune disease diagnostics market 2016-2021
  • Market landscape
    • Market overview
      • Table Global autoimmune disease diagnostics market snapshot
      • Table Key trends in global autoimmune disease diagnostics market
      • Table Global autoimmune disease diagnostics market 2016-2021 ($ millions)
      • Table Opportunity analysis in developed and emerging markets
      • Table Opportunity analysis of global autoimmune diagnostics market
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by disease type
    • Table Global autoimmune disease diagnostics market segmentation by disease type
    • Table Global systemic autoimmune disease diagnostics market 2016
    • Table Global localized autoimmune disease diagnostics market 2016
    • Table Global autoimmune disease diagnostics market segmentation by disease type 2016
    • Table Global autoimmune disease diagnostics market segmentation by disease type 2016
    • Systemic autoimmune disease diagnostics
      • Table Antibodies for diagnosis of different systemic autoimmune diseases
    • Global systemic autoimmune disease market overview
      • Table Global systemic autoimmune disease diagnostics market 2016-2021 ($ millions)
      • Table Global RA diagnostics market 2016-2021 ($ millions)
      • Table Prevalence and incidence of SLE
      • Table Global SLE diagnostics market overview 2016-2021 ($ millions)
      • Table Global systemic autoimmune disease diagnostics market measurement parameters
      • Table Opportunity analysis of systemic autoimmune disease market
    • Localized autoimmune disease diagnostics
      • Table Antibodies used for diagnosis of different localized autoimmune diseases
    • Global localized autoimmune disease diagnostics market overview
      • Table Global localized autoimmune disease diagnostics market 2016-2021 ($ millions)
      • Table Opportunity analysis of localized autoimmune disease diagnostics market
      • Table Global type 1 diabetes diagnostics market 2016-2021 ($ millions)
      • Table Global autoimmune thyroiditis diagnostics market 2016-2021 ($ millions)
      • Table Global localized autoimmune disease diagnostics market measurement parameters
      • Table Global autoimmune disease diagnostics market segmentation by disease type 2016-2021 ($ millions)
      • Table Global autoimmune disease diagnostics market segmentation by disease type 2016-2021
      • Table Analysis of autoimmune disease diagnostics market segmentation by disease type
  • Market segmentation by product type
    • Table Global autoimmune disease diagnostics market segmentation by product type
    • Table Global autoimmune disease diagnostics market segmentation by product type 2016-2021
    • Table Global autoimmune disease diagnostics market segmentation by product type 2016
    • Table Global autoimmune disease diagnostics market segmentation by product type 2016
    • Analyzers
      • Table Some of the analyzers developed by vendors
    • Global autoimmune diseases analyzers market overview
      • Table Global autoimmune diseases analyzers market 2016-2021 ($ millions)
      • Table Opportunity analysis of autoimmune disease analyzers market
    • Assay kits
      • Table Some of the assays kits available in the market
    • Global autoimmune disease assay kits market overview
      • Table Some of the key news related to assay kits
      • Table Global autoimmune diseases assay kits market 2016-2021 ($ millions)
      • Table Opportunity analysis for autoimmune disease assay kits
      • Table Analysis of autoimmune disease diagnostics market by product type
      • Table Global autoimmune disease diagnostics market by product type 2016-2021 ($ millions)
      • Table Global autoimmune disease diagnostics market by product type 2016-2021
  • Market segmentation by test type
    • Table Global autoimmune disease diagnostics market segmentation by test type
    • Table Global autoimmune disease diagnostics market segmentation by test type
    • ANA tests
      • Table Some of the examples of ANA tests
    • CRP
    • Urinalysis test
    • ESR
    • CMP test
    • Other
  • Market segmentation by end-user
    • Hospitals
    • Diagnostic and research laboratories
  • Geographical segmentation
    • Table Global autoimmune disease diagnostics market segmentation by geography 2016-2021
    • Table Global autoimmune disease diagnostics market segmentation by geography 2016
    • Table Global autoimmune disease diagnostics market segmentation by geography 2016
    • Table Global autoimmune disease diagnostics market segmentation by geography 2016-2021 ($ millions)
    • Table Global autoimmune disease diagnostics market segmentation by geography 2016-2021
    • Autoimmune disease diagnostics market in Americas
      • Table Americas: Market overview of autoimmune disease diagnostics
      • Table Comparison of US healthcare system: Before and after reforms
      • Table Autoimmune disease diagnostics market in Americas 2016-2021 ($ millions)
    • Autoimmune disease diagnostics market in EMEA
      • Table Autoimmune disease diagnostics market in EMEA 2016-2021 ($ millions)
      • Table EMEA: Market overview of autoimmune disease diagnostics
    • Autoimmune disease diagnostics market in APAC
      • Table APAC: Market overview of autoimmune disease diagnostics
      • Table Autoimmune disease diagnostics market in APAC 2016-2021 ($ millions)
  • Market drivers
    • Discovery of novel biomarkers leading to improved autoimmune diagnosis
      • Table Key initiatives of vendors fueling the launch of novel biomarkers
    • Advancements in laboratory automation platforms
      • Table Key highlights of laboratory automation
    • Increasing M&A
      • Table Some of the consolidations witnessed during 2015-2016
    • Product approvals and launches
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Limitation of autoimmune disease diagnostics
    • Significant concerns over standardization and quality of immunoassay kits
    • Lack of understanding on the basic etiology of several autoimmune diseases
    • Shortage of skilled technicians for performing diagnostic assays
      • Table Force field analysis of global autoimmune disease diagnostics market
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Focus on companion diagnostic tests
    • Shift from monoplex to multiplex testing
    • Collaboration between pharma and diagnostic companies
    • Growing consumer shift toward direct-to-consumer testing
      • Table Impact of trends on global autoimmune disease diagnostics market
  • Vendor landscape
    • Competitive scenario
      • Table Vendors' product development strategy for end-users
      • Table Competitive structure analysis of global autoimmune diagnostics market 2017-2021
      • Table Strategic success factors for companies in global autoimmune disease diagnostics market
    • Key news
    • Vendors market share 2015
      • Table Market penetration analysis of key vendors in autoimmune disease diagnostics 2015
      • Table Vendors' market share breakdown 2015
  • Key vendor analysis
    • Abbott Laboratories
      • Table Abbott Laboratories: Profile
      • Table Abbott Laboratories: Strength assessment
      • Table Abbott Laboratories: Strategy assessment
      • Table Abbott Laboratories: Opportunity assessment
    • Beckman Coulter
      • Table Beckman Coulter: Key highlights
      • Table Beckman Coulter: Strength assessment
      • Table Beckman Coulter: Strategy assessment
      • Table Beckman Coulter: Opportunity assessment
    • Bio-Rad Laboratories
      • Table Bio-Rad Laboratories: Key highlights
      • Table Bio-Rad Laboratories: Strength assessment
      • Table Bio-Rad Laboratories: Strategy assessment
      • Table Bio-Rad Laboratories: Opportunity assessment
    • EUROIMMUN
      • Table EUROIMMUN: Profile
      • Table EUROIMMUN: Strength assessment
      • Table EUROIMMUN: Strategy assessment
      • Table EUROIMMUN: Opportunity assessment
    • Inova Diagnostics
      • Table Inova Diagnostics: Key highlights
      • Table Inova Diagnostics: Strength assessment
      • Table Inova Diagnostics: Strategy assessment
      • Table Inova Diagnostics: Opportunity assessment
    • Roche Diagnostics
      • Table Roche Diagnostics: Key highlights
      • Table Roche Diagnostics: Strength assessment
      • Table Roche Diagnostics: Strategy assessment
      • Table Roche Diagnostics: Opportunity assessment
    • Siemens Healthcare
      • Table Siemens Healthcare: Key highlights
      • Table Siemens Healthcare: Strength assessment
      • Table Siemens Healthcare: Strategy assessment
      • Table Siemens Healthcare: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report